Pfizer Newsroom

Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32

Futu News07:31

Bernstein Reaffirms Their Hold Rating on Pfizer (PFE)

TipRanks07:30

BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $36

Futu NewsJan 14 21:34

Pfizer's Growth Potential and Strategic Focus Justify Buy Rating Amid Healthcare Policy Shifts

TipRanksJan 14 20:49

Citi Maintains Pfizer(PFE.US) With Hold Rating

Futu NewsJan 14 20:36

Analysts Conflicted on These Healthcare Names: Xencor (XNCR) and Pfizer (PFE)

TipRanksJan 14 19:46

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33

Futu NewsJan 13 21:31

Pfizer's Strategic Initiatives and Growth Prospects Drive Buy Rating

TipRanksJan 13 21:06

Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32

Futu NewsJan 11 23:31

Pfizer Is Maintained at Neutral by UBS

Dow JonesJan 8 23:09

Pfizer Analyst Ratings

BenzingaJan 8 22:59

UBS Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $29

Futu NewsJan 8 20:34

Truist Financial Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $32

Futu NewsJan 8 15:32

Truist Financial Sticks to Its Buy Rating for Pfizer (PFE)

TipRanksJan 8 14:20

TD Cowen Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32

Futu NewsDec 23, 2024 12:31

Pfizer: Navigating Revenue Challenges and Opportunities With a Hold Rating

TipRanksDec 21, 2024 02:00

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $29 to $33

Futu NewsDec 19, 2024 21:00

Truist has lowered the Target Price for Pfizer to 32 dollars.

Gelonghui FinanceDec 19, 2024 17:40

Pfizer Price Target Cut to $32.00/Share From $36.00 by Truist Securities

Dow JonesDec 18, 2024 23:40

Pfizer Analyst Ratings

BenzingaDec 18, 2024 23:28